Every contribution makes a difference
SVI is home to Australia’s largest group of type 1 diabetes researchers who work passionately to better understand this debilitating condition and discover a cure.
Last December, we proudly published the results of a world-first type 1 diabetes clinical trial, that offers new hope for improved treatment options.
At SVI, we remain dedicated to improving the lives of those affected by type 1 diabetes.
Support our groundbreaking diabetes research and help us bring a cure for type 1 diabetes closer to reality.
News and events
26 November 2024
Associate Professor Shiang (Max) Lim, of SVI’s O’Brien Department, has been awarded funding from the Friedreich’s Ataxia Research Alliance (FARA) to better understand the effect of omaveloxolone – a recently FDA-approved drug – on heart disease in people with Friedreich ataxia.
19 November 2024
A new study involving shooting X-rays at crystals has uncovered the precise three-dimensional structure of an enzyme associated with Alzheimer’s disease, allowing researchers to now use powerful computers to discover drug-like molecules to treat the disease.
15 November 2024
The Rising Star program provides critical support to early-mid career researchers, giving them the resources they need to excel in their research and make a lasting impact, said SVI Foundation Board Chair and Rising Star founder, Karen Inge.
Our Research
We are inspired by discovery and driven by purpose. We seek new knowledge to improve health outcomes, reducing the burden...
ResearchOur scientists are working to improve the treatment, diagnosis and prevention of diseases that impact Australians every day.
Find out moreSupport Us